Information for site staff
Every COVID-19 patient in the UK may be invited to participate in the RECOVERY Trial. Randomisation includes the following arms: usual care alone; high-dose vs standard corticosteroids; baricitinib and dimethyl fumarate. The trial is designed to have the least possible impact on NHS staff. You will find Frequently Asked Questions on the site set-up page.
See Update Alert on this page for update details.
update alert
13 may 2022
- recruitment to this comparison should stop immediately (and this possibility has been disabled in the randomisation system)
- higher dose corticosteroids should no longer be administered as part of the trial (patients recently randomised should not be given any further doses, but should receive standard doses (6 mg once daily) if indicated).
- recruitment to this comparison remains open and is encouraged
STUDY PROTOCOL
The RECOVERY Trial protocol is available for use by investigators everywhere to design their own randomised trials that could help identify effective treatments for COVID-19.
DOWNLOADS FOR SITE STAFF
RECOVERY Trial update December 2021 poster
RECOVERY Trial update December 2021 social media graphic
DMC letter of appreciation 14 January 2021
RECOVERY Participant Information Sheet (PIS) + consent form (adults)
RECOVERY Participant Information Sheet (PIS) + consent form (children)
Letter from Chief Medical Officer and NHS England Medical Director (18 August 2020)
Letter from Chief Medical Officer and NHS England Medical Director (16 March 2020)